Radiation and Cancer Physics

PD 12 - Physics 6 - Poster Discussion - Adaptive Planning/Delivery and Motion

1102 - Isotoxic Dose Escalation With Real-Time Imaging on an MR-Linac in Lung Radiation Therapy

Tuesday, October 23
3:03 PM - 3:09 PM
Location: Room 217 C/D

Isotoxic Dose Escalation With Real-Time Imaging on an MR-Linac in Lung Radiation Therapy
L. Bendall1, B. W. Papiez2, M. A. Hawkins3, and J. D. Fenwick4; 1Department of Oncology, University of Oxford, Oxford, United Kingdom, 2Institute of Biomedical Engineering, University of Oxford, Oxford, United Kingdom, 3CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom, 4University of Liverpool, Liverpool, United Kingdom

Purpose/Objective(s): Lung cancer survival is poor with only 5% survival at 10 years. Recent studies suggest that dose escalation in chemoradiotherapy is required to increase survival. However, dose escalation can be limited by dose constraints placed on surrounding organs as risk to limit potentially fatal side effects. MR-linacs offer real-time imaging during radiotherapy. It is hypothesized that MR-linac tracking techniques may allow PTV margin reduction, leading to a meaningful dose escalation with no expected increase in toxicity.

Materials/Methods: To calculate a range of CTV-PTV margins required for real-time tracking on an MR-Linac, MR systematic tracking errors were taken from literature, combined with contouring errors (1 mm) and random per-fraction localisation errors (1 mm) as per van Herk et al. An ideal case of 0 PTV margin and the standard clinical margin were also used for comparison. 4DCT scans from 10 locally advanced NSCLC patients were used to create a range of isotoxic plans based on the mid-ventilation phase and varying PTV margins. Planning aims and constraints were taken from standard clinical practice and the UK IDEAL-CRT trial, and the PTV dose per fraction was increased until one or more OAR constraint-level was reached. The planned doses were used to estimate the expected two-year disease free survival (DFS) using a radiobiological model in lung cancer by Partridge et al. An increase of ≥ 5% DFS was considered clinically useful.

Structure Structure composition Median (range) dose to 95% PTV (Gy) Median (range) BED10 (Gy-1) Median 2-year DFS ratio
PTVstandard ITV + 5 mm (CTV) + 5 mm (PTV) 71.0 (64.1 – 90.0) 76.4 (66.4 - 105.6) 0.36
PTVMRtrack_lo_acc GTVmidV + 5 mm (CTV) + 5 mm (PTV) 72.8 (66.7 – 92.6) 79.1 (70.1 - 109.8) 0.41
PTVMRtrack_hi_acc GTVmidV + 5 mm (CTV) + 2 mm (PTV) 74.8 (69.7 – 109.9) 82.0 (74.4 - 138.8) 0.45
PTVMRtrack_ideal GTVmidV + 5 mm (CTV) + 0 mm (PTV) 76.5 (70.0 – 131.5) 84.6 (74.9 - 177.7) 0.50
Table 1 Prescribed doses achieved during isotoxic dose escalation. ITV – internal target volume, GTVmidV – gross tumour volume on mid-ventilation phase of 4DCT. MR systematic tracking errors of 0.2 mm and 1.35 mm were used for PTVMRtrack_hi_acc and PTVMRtrack_lo_acc. Median isotoxically-prescribed doses of 72.8, 74.8 and 76.5 Gy could be delivered to PTVMRtrack_lo_acc, PTVMRtrack_hi_acc and PTVMRtrack_ideal leading to modelled gains in DFS of 4.2, 9.0 and 14.0% respectively when compared to PTVstandard median dose of 71.0 Gy. Depending on tumour location and proximity of nearby OARs, prescribed doses were limited by constraints on the heart, pulmonary artery, oesophagus, aorta and trachea in 11, 9, 9, 7 and 4 cases respectively.

Conclusion: MR-linacs with the capability of real-time tracking potentially allow the PTV margin to be reduced, leading to notable increases in isotoxically-prescribed doses, and useful gains in modelled two-year disease free survival.

Author Disclosure: L. Bendall: None. B.W. Papiez: None. M.A. Hawkins: None.

Louise Bendall, MS, BS, CSci

University of Oxford Oxford: Employee: Employee


Send Email for Louise Bendall


1102 - Isotoxic Dose Escalation With Real-Time Imaging on an MR-Linac in Lung Radiation Therapy

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Isotoxic Dose Escalation With Real-Time Imaging on an MR-Linac in Lung Radiation Therapy